Scanning electron microscopy in microneedle patch testing

Scanning Electron Microscopy in Microneedle Patch Testing — Expert Summary

Importance of the topic

Microneedle patches are an emerging transdermal delivery platform that enable near‑painless administration of drugs and vaccines through the stratum corneum. Their growing clinical and commercial relevance demands rigorous quality control and performance testing because needle geometry, tip sharpness, material composition, and drug loading directly determine safety and efficacy. High‑resolution imaging combined with elemental analysis is therefore essential to confirm manufacturing consistency, drug incorporation, and functionality after application.

Objectives and overview of the application note

The application note documents how scanning electron microscopy (SEM), augmented with energy‑dispersive X‑ray spectroscopy (EDS) and automated image mapping (AIM), can be applied to evaluate microneedle patches during development and QA. Goals include rapid surveying of an entire patch, high‑magnification inspection of individual needles, chemical confirmation of drug loading, and post‑application assessment to verify skin penetration and release behavior.

Methodology

• Imaging: Desktop SEM was used to capture both overview mosaics of whole patches and tilted side views for detailed assessment of needle profiles and tips.
• Automated image mapping (AIM): Employed to quickly survey the entire patch and produce stitched overviews that reveal needle arrangement and gross defects.
• EDS elemental analysis: Used in situ within the SEM to detect and quantify elements associated with the therapeutic payload or manufacturing residues, enabling verification of drug incorporation.
• Application testing: Microneedle patches were applied to mouse skin to evaluate dissolution, tip integrity, and failure modes; SEM imaging of post‑application needles provided direct evidence of in vivo behavior.

Used instrumentation

• Thermo Scientific Phenom XL G2 Desktop SEM (with automated image mapping capability).
• Energy‑dispersive X‑ray spectroscopy (EDS) integrated with the SEM for elemental mapping and point analysis.

Main results and discussion

• Whole‑patch surveys: AIM mosaics enabled rapid visualization of needle array uniformity and identification of macroscopic defects across the patch area.
• High‑resolution morphology: Tilted SEM views provided side profiles showing needle length, base and tip geometry, and surface morphology—critical parameters for penetration performance.
• Chemical verification by EDS: Elemental spectra identified presence of cerium within drug‑loaded needles, demonstrating successful incorporation of the model therapeutic. Quantitative atomic and weight percentages were reported to corroborate loading.
• Post‑application outcomes: Two distinct behaviors were observed after mouse application—(a) needles with dissolved tips consistent with successful drug release and skin penetration, and (b) needles with bent tips indicative of mechanical failure or insufficient penetration. These contrasting outcomes illustrate how SEM can reveal both successful and problematic performance modes and guide design or process adjustments.

Benefits and practical applications of the method

• Non‑destructive and high‑resolution assessment of needle geometry for incoming QC and process troubleshooting.
• Rapid, spatially resolved chemical confirmation of drug presence inside needles using EDS, supporting batch release decisions and formulation verification.
• Ability to document failure modes after application testing (e.g., tip bending, incomplete dissolution), enabling targeted design improvements such as tip sharpening, length adjustment, or material selection.
• Automated mapping reduces inspection time for whole patches and standardizes visual QC workflows in development and manufacturing environments.

Future trends and potential uses

• Integration of higher‑sensitivity detectors and correlative techniques (e.g., cryo‑SEM for hydrated samples, X‑ray microscopy) to better preserve and image polymeric and hydrogel microneedles in near‑native states.
• Advanced image analysis and machine learning applied to AIM mosaics to automate defect detection, dimensional metrology, and predictive QA scoring across large sample sets.
• Expanded use of quantitative elemental mapping to monitor formulation distribution, trace contaminants, and coating uniformity at production scale.
• Correlative in vivo/ex vivo workflows linking SEM/EDS observations with pharmacokinetic and biological endpoints to accelerate formulation optimization and regulatory dossiers.

Conclusion

SEM coupled with EDS and automated image mapping is a powerful toolkit for characterizing microneedle patches. It supports essential activities across development and quality assurance: morphological inspection, chemical verification of payload, and post‑application failure analysis. These capabilities help manufacturers optimize geometry, validate drug loading, and investigate mechanical or material failures detected during in vivo testing.

References

• Liu M, Wei B. Scanning electron microscopy in microneedle patch testing. Thermo Fisher Scientific Application Note AN0239‑EN‑04‑2024. 2024.